By activating downstream arousal pathways of OX2R, these agonists not only simultaneously improve EDS, cataplexy, and nocturnal sleep fragmentation, but also enhance overall wakefulness quality—including heightened attention and reduced anxiety. This evidence concerns the gene HCRTR2 and Anxiety.